{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T08:29:05Z","timestamp":1792398545054,"version":"4.4.0"},"reference-count":36,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"4","license":[{"start":{"date-parts":[[2020,4,24]],"date-time":"2020-04-24T00:00:00Z","timestamp":1587686400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest. Ophthalmol. Vis. Sci."],"published-print":{"date-parts":[[2020,4,24]]},"DOI":"10.1167\/iovs.61.4.31","type":"journal-article","created":{"date-parts":[[2020,4,24]],"date-time":"2020-04-24T13:31:05Z","timestamp":1587735065000},"page":"31","source":"Crossref","is-referenced-by-count":43,"title":["In Vivo CRISPR\/Cas9-Mediated Genome Editing Mitigates Photoreceptor Degeneration in a Mouse Model of X-Linked Retinitis Pigmentosa"],"prefix":"10.1167","volume":"61","author":[{"given":"Shuang","family":"Hu","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Peking University Third Hospital, Beijing Key Laboratory of Restoration of Damaged Ocular Nerve, Beijing, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Du","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Peking University Third Hospital, Beijing Key Laboratory of Restoration of Damaged Ocular Nerve, Beijing, P.R. China"},{"name":"Department of Anatomy, Histology, and Embryology, Key Laboratory of Carcinogenesis and Translational Research, Ministry of Education, and State Key Laboratory of Natural and Biomimetic Drugs, Peking University Health Science Center, Beijing, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningning","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Peking University Third Hospital, Beijing Key Laboratory of Restoration of Damaged Ocular Nerve, Beijing, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruixuan","family":"Jia","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Peking University Third Hospital, Beijing Key Laboratory of Restoration of Damaged Ocular Nerve, Beijing, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinlu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Institute of Systems Biomedicine, Beijing Key Laboratory of Tumor Systems Biology, Department of Pathology, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaozhen","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Peking University Third Hospital, Beijing Key Laboratory of Restoration of Damaged Ocular Nerve, Beijing, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Peking University Third Hospital, Beijing Key Laboratory of Restoration of Damaged Ocular Nerve, Beijing, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27","reference":[{"key":"bib1","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1006\/geno.2002.6815","article-title":"X-linked recessive atrophic macular degeneration from RPGR mutation","volume":"80","author":"Ayyagari","year":"2002","journal-title":"Genomics"},{"key":"bib2","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1086\/339620","article-title":"X-linked cone-rod dystrophy (locus COD1): identification of mutations in RPGR exon ORF15","volume":"70","author":"Demirci","year":"2002","journal-title":"American J Hum Genet"},{"key":"bib3","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/S0002-9394(03)01459-4","article-title":"Increasing evidence for syndromic phenotypes associated with RPGR mutations","volume":"137","author":"Iannaccone","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"bib4","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1038\/78182","article-title":"Mutational hot spot within a new RPGR exon in X-linked retinitis pigmentosa","volume":"25","author":"Vervoort","year":"2000","journal-title":"Nat Genet"},{"key":"bib5","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1093\/hmg\/11.9.993","article-title":"Different RPGR exon ORF15 mutations in Canids provide insights into photoreceptor cell degeneration","volume":"11","author":"Zhang","year":"2002","journal-title":"Hum Mol Genet"},{"key":"bib6","doi-asserted-by":"publisher","first-page":"e35865","DOI":"10.1371\/journal.pone.0035865","article-title":"Rd9 is a naturally occurring mouse model of a common form of retinitis pigmentosa caused by mutations in RPGR-ORF15","volume":"7","author":"Thompson","year":"2012","journal-title":"PLoS One"},{"key":"bib7","doi-asserted-by":"publisher","first-page":"3649","DOI":"10.1073\/pnas.97.7.3649","article-title":"A retinitis pigmentosa GTPase regulator (RPGR)-deficient mouse model for X-linked retinitis pigmentosa (RP3)","volume":"97","author":"Hong","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"bib8","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/mt.2012.280","article-title":"A comprehensive review of retinal gene therapy","volume":"21","author":"Boye","year":"2013","journal-title":"Mol Ther"},{"key":"bib9","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/S0140-6736(13)62117-0","article-title":"Retinal gene therapy in patients with choroideremia: initial findings from a phase 1\/2 clinical trial","volume":"383","author":"MacLaren","year":"2014","journal-title":"Lancet"},{"key":"bib10","doi-asserted-by":"publisher","first-page":"3956","DOI":"10.1093\/hmg\/ddv134","article-title":"A long-term efficacy study of gene replacement therapy for RPGR-associated retinal degeneration","volume":"24","author":"Wu","year":"2015;","journal-title":"Hum Mol Genet"},{"key":"bib11","doi-asserted-by":"publisher","first-page":"e1380","DOI":"10.1002\/wsbm.2017.9.issue-4","article-title":"Therapeutic genome engineering via CRISPR-Cas systems","volume":"9","author":"Moreno","year":"2017","journal-title":"Wiley Interdiscip Rev Syst Biol Med"},{"key":"bib12","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1126\/science.1254445","article-title":"Prevention of muscular dystrophy in mice by CRISPR\/Cas9\u2013mediated editing of germline DNA","volume":"345","author":"Long","year":"2014","journal-title":"Science"},{"key":"bib13","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/mt.2015.220","article-title":"In vivo CRISPR\/Cas9 gene editing corrects retinal dystrophy in the S334ter-3 rat model of autosomal dominant retinitis pigmentosa","volume":"24","author":"Bakondi","year":"2016","journal-title":"Mol Ther"},{"key":"bib14","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/s41591-018-0327-9","article-title":"Development of a gene-editing approach to restore vision loss in Leber congenital amaurosis type 10","volume":"25","author":"Maeder","year":"2019","journal-title":"Nat Med"},{"key":"bib15","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.cell.2014.09.014","article-title":"CRISPR-Cas9 knockin mice for genome editing and cancer modeling","volume":"159","author":"Platt","year":"2014","journal-title":"Cell"},{"key":"bib16","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/S0140-6736(17)31868-8","article-title":"Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial","volume":"390","author":"Russell","year":"2017","journal-title":"Lancet"},{"key":"bib17","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/nbt.2623","article-title":"High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells","volume":"31","author":"Fu","year":"2013","journal-title":"Nat Biotechnol"},{"key":"bib18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10633-014-9473-7","article-title":"ISCEV standard for full-field clinical electroretinography (2015 update)","volume":"130","author":"McCulloch","year":"2015","journal-title":"Doc Ophthalmol"},{"key":"bib19","first-page":"235903","article-title":"Hi-TOM: a platform for high-throughput tracking of mutations induced by CRISPR\/Cas systems","author":"Liu","year":"2018:","journal-title":"bioRxiv"},{"key":"bib20","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1038\/nprot.2013.143","article-title":"Genome engineering using the CRISPR-Cas9 system","volume":"8","author":"Ran","year":"2013","journal-title":"Nat Protoc"},{"key":"bib21","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.beem.2004.02.001","article-title":"Pitfalls of animal model systems in ageing research","volume":"18","author":"Flurkey","year":"2004","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"bib22","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1167\/iovs.03-0787","article-title":"Dominant, gain-of-function mutant produced by truncation of RPGR","volume":"45","author":"Hong","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib23","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1016\/j.ymthe.2017.05.005","article-title":"Codon-optimized RPGR improves stability and efficacy of AAV8 gene therapy in two mouse models of X-linked retinitis pigmentosa","volume":"25","author":"Fischer","year":"2017","journal-title":"Mol Ther"},{"key":"bib24","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.exer.2015.06.007","article-title":"RPGR: its role in photoreceptor physiology, human disease, and future therapies","volume":"138","author":"Megaw","year":"2015","journal-title":"Exp Eye Res"},{"key":"bib25","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/nm.3793","article-title":"Therapeutic genome editing: prospects and challenges","volume":"21","author":"Cox","year":"2015","journal-title":"Nat Med"},{"key":"bib26","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.stem.2013.11.002","article-title":"Functional repair of CFTR by CRISPR\/Cas9 in intestinal stem cell organoids of cystic fibrosis patients","volume":"13","author":"Schwank","year":"2013","journal-title":"Cell Stem Cell"},{"key":"bib27","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/nbt.2884","article-title":"Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype","volume":"32","author":"Yin","year":"2014","journal-title":"Nat Biotechnol"},{"key":"bib28","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1101\/gr.162339.113","article-title":"Analysis of off-target effects of CRISPR\/Cas-derived RNA-guided endonucleases and nickases","volume":"24","author":"Cho","year":"2014","journal-title":"Genome Res"},{"key":"bib29","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1038\/eye.2008.382","article-title":"Ocular immune privilege","volume":"23","author":"Taylor","year":"2009","journal-title":"Eye"},{"key":"bib30","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/nbt.2647","article-title":"DNA targeting specificity of RNA-guided Cas9 nucleases","volume":"31","author":"Hsu","year":"2013","journal-title":"Nat Biotechnol"},{"key":"bib31","doi-asserted-by":"publisher","first-page":"7473","DOI":"10.1093\/nar\/gku402","article-title":"CRISPR\/Cas9 systems have off-target activity with insertions or deletions between target DNA and guide RNA sequences","volume":"42","author":"Lin","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"bib32","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.ymthe.2016.12.006","article-title":"CRISPR\/Cas9-mediated genome editing as a therapeutic approach for Leber congenital amaurosis 10","volume":"25","author":"Ruan","year":"2017","journal-title":"Mol Ther"},{"key":"bib33","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/nature20565","article-title":"In vivo genome editing via CRISPR\/Cas9 mediated homology-independent targeted integration","volume":"540","author":"Suzuki","year":"2016","journal-title":"Nature"},{"key":"bib34","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1146\/annurev-genet-051710-150955","article-title":"Regulation of homologous recombination in eukaryotes","volume":"44","author":"Heyer","year":"2010","journal-title":"Ann Rev Genet"},{"key":"bib35","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.neuron.2017.10.004","article-title":"Virus-mediated genome editing via homology-directed repair in mitotic and postmitotic cells in mammalian brain","volume":"96","author":"Nishiyama","year":"2017","journal-title":"Neuron"},{"key":"bib36","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/nature17946","article-title":"Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage","volume":"533","author":"Komor","year":"2016","journal-title":"Nature"}],"container-title":["Investigative Opthalmology & Visual Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/iovs.arvojournals.org\/article.aspx?articleid=2765263","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:31:17Z","timestamp":1791927077000},"score":1,"resource":{"primary":{"URL":"https:\/\/iovs.arvojournals.org\/article.aspx?articleid=2765263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,24]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4,9]]}},"URL":"https:\/\/doi.org\/10.1167\/iovs.61.4.31","relation":{},"ISSN":["1552-5783"],"issn-type":[{"value":"1552-5783","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4,24]]}}}